Diabetes medication(s)-Insulin Posts on Medivizor
Navigation Menu

Diabetes medication(s)-Insulin Posts on Medivizor

Does insulin glargine-300 reduce the risk of hypoglycemia in patients with type 1 diabetes?

Does insulin glargine-300 reduce the risk of hypoglycemia in patients with type 1 diabetes?

Posted by on Jul 5, 2020 in Diabetes mellitus | 0 comments

In a nutshell This study compared the risk of severe hypoglycemia (dangerously low blood glucose levels) with insulin glargine-100 (Lantus) and insulin glargine-300 (Toujeo) for patients with type 1 diabetes (T1D). It found that both medications improved glucose control, and insulin glargine-300 had a lower risk of hypoglycemia. Some background T1D is...

Read More

How safe and effective is non-insulin drug dapagliflozin long-term for patients with uncontrolled type 1 diabetes?

How safe and effective is non-insulin drug dapagliflozin long-term for patients with uncontrolled type 1 diabetes?

Posted by on May 17, 2020 in Diabetes mellitus | 0 comments

In a nutshell This study compared two doses of dapagliflozin (Farxiga) to a placebo to determine how effective and safe they were long-term for patients with uncontrolled type 1 diabetes (T1D). The results showed that both doses were able to reduce blood glucose levels and body weight but increased the risk of ketoacidosis. Some background...

Read More

Can a non-insulin drug improve treatment results for patients with uncontrolled type 2 diabetes taking insulin?

Posted by on May 6, 2020 in Diabetes mellitus | 0 comments

In a nutshell This study examined if non-insulin drug lixisenatide (Lyxumia) boosted treatment results from insulin glargine (Lantus) in patients with uncontrolled type 2 diabetes (T2D). Patients who received lixisenatide and glargine had improved blood glucose control and no significant increase in side effects. Some background Uncontrolled...

Read More

Looking for patients with diabetes receiving insulin to test mobile app

Posted by on Dec 20, 2019 in Diabetes mellitus | 0 comments

In a nutshell This study is looking for patients with diabetes taking insulin to test a mobile app that helps patients understand how blood glucose levels change. The main outcome that will be measured is the average blood glucose level at the beginning versus the end of the study. This study is recruiting in Boston, MA, the US. The details...

Read More

Evaluating the Diabeloop insulin delivery system for patients with type 1 diabetes

Posted by on Nov 3, 2019 in Diabetes mellitus | 0 comments

In a nutshell This study is comparing the effectiveness of two insulin delivery systems for patients with type 1 diabetes (T1D). The authors concluded that the Diabeloop system was more effective and better reduced high blood glucose levels in these patients. Some background Controlling blood glucose levels is an essential part of diabetes management....

Read More

How effective and safe is a closed-loop insulin pump for patients with type 1 diabetes?

Posted by on Oct 30, 2019 in Diabetes mellitus | 0 comments

In a nutshell This study compared the effectiveness and safety of a closed-loop and sensor-augmented insulin pumps for patients with Type 1 diabetes (T1D). The authors found that the closed-loop device was more effective but had more side effects for these patients. Some background The main goal of treatment for T1D is to balance blood glucose...

Read More

Can ipragliflozin treatment help lower insulin dose in patients with T2D receiving insulin therapy?

Posted by on Oct 13, 2019 in Diabetes mellitus | 0 comments

In a nutshell This study evaluated the safety and effectiveness of ipragliflozin (Suglat) in patients with type 2 diabetes (T2D). This study concluded that ipragliflozin helped reduce insulin dose by 30%, with minimal side effects. Some background Treatment for T2D aims to achieve good blood glucose control while avoiding hypoglycemia (dangerously low...

Read More

Is IDegLira more effective than standard insulin for patients with Type 2 diabetes?

Posted by on Sep 4, 2019 in Diabetes mellitus | 0 comments

In a nutshell This study compared insulin degludec/liraglutide (IDegLira) to standard insulin in patients with uncontrolled Type 2 diabetes (T2D).  The authors concluded that IDegLira improved patient compliance to treatment and reduced treatment-related stress compared to conventional insulin. Some background One of the main goals of treatment...

Read More

Can nutritional supplements help reduce hypoglycemia in patients with Type 2 diabetes?

Posted by on Sep 1, 2019 in Diabetes mellitus | 0 comments

In a nutshell This study examined if nutritional supplements can reduce the rate of hypoglycemia in patients with Type 2 diabetes (T2D). This study concluded that these supplements helped reduce hypoglycemia and lowered mortality risk for these patients. Some background Treatment for T2D, such as insulin, can cause blood sugar levels to...

Read More

Looking for patients with type 1 diabetes to compare two insulin types in an automated insulin pump

Posted by on Aug 31, 2019 in Diabetes mellitus | 0 comments

In a nutshell This study is comparing the effectiveness of two types of insulin when they are given using an automated insulin pump to patients with type 1 diabetes (T1D). The main outcome will be to examine patients’ blood glucose levels after 6 weeks. This study is recruiting in Austin, TX, US. The details T1D is a disease where...

Read More